lactose has been researched along with chlorpheniramine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (25.00) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ellis, EF; St Pierre, JP; Wanderer, AA | 1 |
Augsburger, LL; Koparkar, AD; Shangraw, RF | 1 |
Cao, JB; Qian, JE; Sun, HT; Wang, YL | 1 |
Brown, S; Gerstenhaber, B; Lach, E; Schachter, EN | 1 |
Schwartz, JB; Tang, L; Wigent, RJ | 1 |
Bodmeier, R; Kranz, H; Peppas, NA; Siepmann, J | 1 |
Porter, SC; Schnaare, RL; Schwartz, JB; Tang, L; Wigent, RJ | 1 |
MACAULAY, DB; PLACKETT, RL; WILSON, CW | 1 |
Cheong, WS; Heng, PW; Wong, TW | 1 |
Heng, PW; Karande, AD; Liew, CV | 3 |
Chan, LW; Heng, PWS; Lee, WB; Widjaja, E | 3 |
2 trial(s) available for lactose and chlorpheniramine
Article | Year |
---|---|
Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo.
Topics: Adolescent; Adult; Child; Chlorpheniramine; Clinical Trials as Topic; Cold Temperature; Cyproheptadine; Double-Blind Method; Female; Humans; Lactose; Male; Middle Aged; Placebos; Urticaria | 1977 |
Histamine blocking agents in healthy and asthmatic subjects.
Topics: Asthma; Bronchi; Bronchial Spasm; Chlorpheniramine; Cimetidine; Forced Expiratory Flow Rates; Guanidines; Histamine; Humans; Lactose; Lung Volume Measurements; Receptors, Histamine | 1982 |
14 other study(ies) available for lactose and chlorpheniramine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Intrinsic dissolution rates of tablet filler-binders and their influence on the dissolution of drugs from tablet formulations.
Topics: Calcium; Chemistry, Pharmaceutical; Chlorpheniramine; Hydrochlorothiazide; Hydrogen-Ion Concentration; Kinetics; Lactose; Solubility; Tablets | 1990 |
[Determination of toldrin under the interference of lactose by linear combination method of absorbances].
Topics: Chlorpheniramine; Lactose; Methods; Pharmaceutical Vehicles | 1988 |
Drug release from film-coated chlorpheniramine maleate nonpareil beads: water influx and development of a new drug release model.
Topics: Algorithms; Chlorpheniramine; Delayed-Action Preparations; Drug Compounding; Excipients; Kinetics; Lactose; Methylcellulose; Microspheres; Models, Theoretical; Oxazines; Particle Size; Solubility; Surface Properties; Water | 1999 |
Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles.
Topics: Algorithms; Chlorpheniramine; Delayed-Action Preparations; Drug Carriers; Lactose; Methylcellulose; Models, Theoretical; Oxazines; Particle Size; Propranolol; Reproducibility of Results | 2000 |
Drug release from film-coated chlorpheniramine maleate nonpareil beads: effect of water-soluble polymer, coating level, and soluble core material.
Topics: Anti-Allergic Agents; Chemistry, Pharmaceutical; Chlorpheniramine; Lactose; Mathematics; Methylcellulose; Oxazines; Permeability; Solubility; Sucrose | 2000 |
AN EVALUATION OF THE EFFICIENCY OF ANTI-HISTAMINES FOR THE TREATMENT OF HAY-FEVER.
Topics: Anti-Allergic Agents; Chlorpheniramine; Histamine; Histamine H1 Antagonists; Humans; Lactose; Promethazine; Rhinitis, Allergic, Seasonal | 1963 |
Impact of a non-meltable additive on melt agglomeration with a hydrophobic meltable binder in high-shear mixer.
Topics: Chemistry, Pharmaceutical; Chlorpheniramine; Cottonseed Oil; Crystallization; Excipients; Lactose; Particle Size; Porosity; Powders; Rheology; Surface Tension; Technology, Pharmaceutical; Tensile Strength; Viscosity; Wettability | 2007 |
In-line quantification of drug and excipients in cohesive powder blends by near infrared spectroscopy.
Topics: Calibration; Cellulose; Chemistry, Pharmaceutical; Chlorpheniramine; Equipment Design; Excipients; Lactose; Least-Squares Analysis; Particle Size; Powders; Reproducibility of Results; Spectroscopy, Near-Infrared; Stearic Acids; Surface Properties; Technology, Pharmaceutical | 2010 |
Calibration sampling paradox in near infrared spectroscopy: a case study of multi-component powder blend.
Topics: Calibration; Cellulose; Chemistry, Pharmaceutical; Chlorpheniramine; Lactose; Least-Squares Analysis; Models, Statistical; Powders; Spectroscopy, Near-Infrared; Stearic Acids; Technology, Pharmaceutical | 2010 |
In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process.
Topics: Calibration; Cellulose; Chemistry, Pharmaceutical; Chlorpheniramine; Drug Compounding; Equipment Design; Excipients; Guidelines as Topic; Lactose; Least-Squares Analysis; Linear Models; Principal Component Analysis; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared; Stearic Acids; Surface Properties; Tablets; Technology, Pharmaceutical | 2010 |
Investigating the effect and mechanism of particle size distribution variability on mixing using avalanche testing and multivariate modelling.
Topics: Cellulose; Chlorpheniramine; Drug Compounding; Excipients; Lactose; Least-Squares Analysis; Multivariate Analysis; Particle Size | 2019 |
Near infrared spectroscopy for rapid and in-line detection of particle size distribution variability in lactose during mixing.
Topics: Cellulose; Chlorpheniramine; Drug Compounding; Excipients; Lactose; Least-Squares Analysis; Particle Size; Quality Control; Spectroscopy, Near-Infrared | 2019 |
De-risking excipient particle size distribution variability with automated robust mixing: Integrating quality by design and process analytical technology.
Topics: Automation; Cellulose; Chlorpheniramine; Drug Compounding; Excipients; Lactose; Particle Size; Powders; Quality Control; Spectroscopy, Near-Infrared; Technology, Pharmaceutical; Time Factors | 2020 |